Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina (31)

2024

  1. Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach

    Cell death & disease, Vol. 15, Núm. 2, pp. 127

2023

  1. Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds

    Pharmaceutics, Vol. 15, Núm. 5

  2. Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2153-2165

2022

  1. Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 171, pp. 39-49

2021

  1. Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis

    Clinical Epigenetics, Vol. 13, Núm. 1

  2. Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo

    Journal of Controlled Release, Vol. 331, pp. 198-212

2020

  1. Development and validation of a sample entropy-based method to identify complex patient-ventilator interactions during mechanical ventilation

    Scientific Reports, Vol. 10, Núm. 1

  2. Intracellular delivery of anti-SMC2 antibodies against cancer stem cells

    Pharmaceutics, Vol. 12, Núm. 2

  3. Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 24

2019

  1. Pivotal role of AKT2 during dynamic phenotypic change of breast cancer stem cells

    Cancers, Vol. 11, Núm. 8

2018

  1. AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells

    Drug Delivery, Vol. 25, Núm. 1, pp. 961-972

  2. Dynamism, sensitivity, and consequences of mesenchymal and stem-like phenotype of cancer cells

    Stem Cells International, Vol. 2018

  3. Efficient EFGR mediated siRNA delivery to breast cancer cells by Cetuximab functionalized Pluronic® F127/Gelatin

    Chemical Engineering Journal, Vol. 340, pp. 81-93

  4. Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer

    British Journal of Cancer, Vol. 118, Núm. 1, pp. 106-116

2017

  1. Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer

    Scientific Reports, Vol. 7

  2. Loss of the EPH receptor B6 contributes to colorectal cancer metastasis

    Scientific Reports, Vol. 7

2016

  1. Cancer stem cells and personalized cancer nanomedicine

    Nanomedicine, Vol. 11, Núm. 3, pp. 307-320

2015

  1. Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, Núm. 8, pp. 1883-1892

  2. Highly expressed genes in rapidly proliferating tumor cells as new targets for colorectal cancer treatment

    Clinical Cancer Research, Vol. 21, Núm. 16, pp. 3695-3704

2014

  1. Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer

    Cancer Research, Vol. 74, Núm. 12, pp. 3238-3247